1.5% levofloxacin ophthalmic solution
Sponsors
Santen Inc.
Conditions
CataractCorneal TransplantationHealthy
Phase 4
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
CompletedNCT00630019
Start: 2008-02-29Target: 96Updated: 2009-02-06
Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators
CompletedNCT00703313
Start: 2008-05-31Target: 72Updated: 2009-02-06
Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
TerminatedNCT00764582
Start: 2008-09-30Target: 60Updated: 2009-08-26